Genpact Limited (G) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Genpact Limited

    NYSE: G · Real-Time Price · USD
    42.20
    0.41 (0.98%)
    At close: Sep 26, 2025, 3:59 PM
    42.22
    0.04%
    After-hours: Sep 26, 2025, 06:08 PM EDT

    Genpact Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 4.77B 4.48B 4.37B 4.02B
    Cost of Revenue
    		 3.08B 2.91B 2.83B 2.59B
    Gross Profit
    		 1.69B 1.57B 1.54B 1.43B
    Operating Income
    		 702.06M 630.86M 502.15M 509M
    Interest Income
    		 32.29M 18.37M 5.9M 6.88M
    Pretax Income
    		 676.82M 602.22M 465.24M 483.13M
    Net Income
    		 513.67M 631.25M 353.4M 369.45M
    Selling & General & Admin
    		 967.14M 913.06M 938.38M 865.72M
    Research & Development
    		 n/a n/a n/a n/a
    Other Expenses
    		 20.86M 26.75M 95.86M 57.24M
    Operating Expenses
    		 988M 939.81M 1.03B 922.96M
    Interest Expense
    		 79.51M 66.31M 58.1M 58.31M
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 4.07B 3.85B 3.87B 3.51B
    Income Tax Expense
    		 163.15M -29.03M 111.83M 113.68M
    Shares Outstanding (Basic)
    		 178.39M 182.35M 184.18M 187.8M
    Shares Outstanding (Diluted)
    		 180.44M 185.14M 188.09M 192.96M
    EPS (Basic)
    		 2.88 3.46 1.92 1.97
    EPS (Diluted)
    		 2.85 3.41 1.88 1.91
    EBITDA
    		 852.58M 772.52M 652.86M 709.01M
    EBIT
    		 756.33M 668.53M 523.34M 541.44M
    Depreciation & Amortization
    		 96.25M 103.99M 129.52M 167.57M

    Add to Watchlist